Nuvation Bio Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 86.85 million compared to USD 41.66 million a year ago. Basic loss per share from continuing operations was USD 0.44 compared to USD 0.43 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | +0.66% | +0.99% | +101.99% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.99% | 754M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Inc. Reports Earnings Results for the Full Year Ended December 31, 2021